Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

LED Medical Diagnostics Inc LEDIF

"LED Medical Diagnostics Inc is a Canada based company engaged in development and marketing of a medical device under the trade name VELscope which is used in the dental industry to help identify oral soft tissue abnormalities including those which may be cancerous or precancerous. In addition, the company also features a Digital division that provides dentists and oral health diagnostic imaging products and software. It principally operates in North America."


GREY:LEDIF - Post by User

Bullboard Posts
Comment by Alexsorenthor34on Mar 25, 2015 1:00am
113 Views
Post# 23557925

RE:SG&A growth out of control here

RE:SG&A growth out of control hereAs for the mushrooming SG&A expenses. I will quote Nick Hodge on this one. "Many people don't like Mushrooms because they're grown in s#!+. But it's a necessary fertilizer. And I think that's what's going on here. Remember the reasons we are invested in this company. It's going from a single-product story with exclusive distribution agreements to a multi faceted dental distribution company selling it's own and other firms' products through its own channels and non-exclusive deals. The rampant rise in spending is the cost of that transition — bringing in new management, building a new sales office and team, attending multiple trade shows, purchasing demo equipment, and building inventories. As the company notes in the Management Discussion & Analysis of earnings: To date, the Company has had a significant portion of its revenues derived from sales to its former exclusive distribution partners. The Company has transitioned to a non-exclusive distribution structure by terminating all previously exclusive distribution partnerships and entering non-exclusive distribution agreements with multiple distribution partners. During this transition period,the Company underwent a general shift in resources to sales and marketing from administration as new distribution agreements were negotiated. The cost of building inventory is mentioned several times in that discussion — a thinly-veiled hint that sales will be drastically higher in the near term. It had 13 employees at the end of the third quarter last year. It has 40 now. Administrative employees remained the same (and administration costs went down), R&D employees remained the same, but sales and marketing employees grew 386%, from seven employees to 34. What's more, the company reiterated its full-year sales guidance of $9-11 million, which tells me it's still expecting a very robust fourth quarter. Bottom line is the company, even if it doesn't quite get to $9 million, will still at least triple revenues in 2014 compared to 2013. To me, that's a sign the transition is working. I'm sticking with it."
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse